Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Graystone who wrote (4889)	7/15/1998 2:58:00 PM
From: Mark the K	Read Replies (2) \| Respond to of 7041

Hiya Greystone, Why don't you stop being rude? I have been a lurker here for quite some time (read my informative posts on Yahoo's ZONA thread) and your rudeness has finally gotten me to take the time to respond. Instead of being rude, tell me why Vasomax will get approved with its ridiculous 51% (over 38% for placebo) for mildly dysfunctional men? "It won't" is my guess. If it does, it will get little or none of the market. It is a pathetic also-ran. It's real value is only higher than vivus because they have more cash and they have pumped the suckers. Time now for a dump I imagine. And check the rumor, Asensio, the rumor says, will be writing a new Zona paper. That's good for -5 to -10... Anyway, as I have said many times over on Yahoo ZONA: "I love ZONA" it is so predictable. My trip to Italy, paid for with my latest profits on my June Zona puts, was great. My next trip will be paid for by August Zona puts, it's a guarantee. Mark